Comment
doi: 10.1038/nrclinonc.2010.88.
Pediatric oncology: Fusion-gene status crucial in RMS
- PMID: 20614557
- DOI: 10.1038/nrclinonc.2010.88
Item in Clipboard
Comment
Pediatric oncology: Fusion-gene status crucial in RMS
Nat Rev Clin Oncol.
2010 Jul.
No abstract available
Comment on
-
Fusion gene-negative alveolar rhabdomyosarcoma is clinically and molecularly indistinguishable from embryonal rhabdomyosarcoma.J Clin Oncol. 2010 May 1;28(13):2151-8. doi: 10.1200/JCO.2009.26.3814. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351326
Similar articles
-
Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.Pediatr Blood Cancer. 2017 Dec;64(12):10.1002/pbc.26645. doi: 10.1002/pbc.26645. Epub 2017 May 18. Pediatr Blood Cancer. 2017. PMID: 28521080 Free PMC article.
-
Histology and fusion status in rhabdomyosarcoma.Am Soc Clin Oncol Educ Book. 2013:425-8. doi: 10.14694/EdBook_AM.2013.33.425. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714565 Review.
-
ALK expression in rhabdomyosarcomas: correlation with histologic subtype and fusion status.Pediatr Dev Pathol. 2009 Jul-Aug;12(4):275-83. doi: 10.2350/08-03-0434.1. Pediatr Dev Pathol. 2009. PMID: 18788887
-
Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma.Front Genet. 2020 Dec 10;11:606274. doi: 10.3389/fgene.2020.606274. eCollection 2020. Front Genet. 2020. PMID: 33362864 Free PMC article.
-
Future directions in risk stratification and therapy for advanced pediatric genitourinary rhabdomyosarcoma.Urol Oncol. 2016 Feb;34(2):103-15. doi: 10.1016/j.urolonc.2015.09.013. Epub 2015 Oct 28. Urol Oncol. 2016. PMID: 26519985 Review.
Cited by
-
Prevalence of alternative lengthening of telomeres in pediatric sarcomas determined by the telomeric DNA C-circle assay.Front Oncol. 2024 Aug 19;14:1399442. doi: 10.3389/fonc.2024.1399442. eCollection 2024. Front Oncol. 2024. PMID: 39224814 Free PMC article.
-
Fusion Oncoproteins in Childhood Cancers: Potential Role in Targeted Therapy.J Pediatr Pharmacol Ther. 2021;26(6):541-555. doi: 10.5863/1551-6776-26.6.541. Epub 2021 Aug 16. J Pediatr Pharmacol Ther. 2021. PMID: 34421403 Free PMC article. Review.
-
Identify potential driver genes for PAX-FOXO1 fusion-negative rhabdomyosarcoma through frequent gene co-expression network mining.Front Oncol. 2023 Jan 30;13:1080989. doi: 10.3389/fonc.2023.1080989. eCollection 2023. Front Oncol. 2023. PMID: 36793601 Free PMC article.
References
-
- J Clin Oncol. 2010 May 1;28(13):2151-8 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
